Advent to buy 50.1% stake in Suven Pharma for $762 million
Advent International, a global private equity investor, will buy a 50.1% stake in India’s Suven Pharmaceuticals for INR 63,130 million ($762 million), according.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Advent International, a global private equity investor, will buy a 50.1% stake in India’s Suven Pharmaceuticals for INR 63,130 million ($762 million), according.